{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 224,
  "pageCount": 239,
  "prevPage": 223,
  "nextPage": 225,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/224",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-224",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We find this troubling as high volume implanters drive 90% of the SCS industry's revenue.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b34b-55c6366c7dc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "One KOL candidly admitted that he was “aggressive” in pushing trials and pointed to colleagues lining up “10 or 12 of them” one day a week with no intention of doing a permanent implant. Another KOL says he sees widespread abuse in his role working with an insurer, and that he just assumes that any high volume implanter is suspicious. We find this troubling as high volume implanters drive 90% of the SCS industry’s revenue.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baa8ef47-ad17-4fb4-bebb-fa2ce23c9fbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.83,
        "x": 0.11,
        "y": 0.41
      },
      "kind": "quote",
      "text": "I work with an insurance company so I see lots of requests for stuff. When I see high stimulator volumes I’m suspicious. I deny a lot from some high volume implanters They do 5X more surgeries. You can make money on the trial, but you usually don’t make money on the implant. And there have been a lot of patients who are just trialed for no reason by shitty doctors just wanting to making money on the trial knowing full-well they’re not going to proceed with the implant. There’s a lot of crap going on in that regard. That’s been ripe for abuse.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49502563-bc1b-4135-babb-c559b1735e0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.83,
        "x": 0.11,
        "y": 0.67
      },
      "kind": "quote",
      "text": "We used to do a lot of trials and they were quite lucrative. Especially for a guy like me who did a lot and I’m kind of aggressive, like with my billing. They used to pay us per lead. So if you put in four leads, you’d make a lot of money. I would buy the equipment myself so that’s where all the money was instead of the hospital buying the equipment. There were a bunch of guys that were just putting in all these trials on Medicare patients, where you don’t have to get authorization. One day a week, they’d line up 10 or 12 of them. Put the trials in and I don’t know if they even cared about implanting a device after the trials.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db81c8da-d63d-4621-9f79-ffcc60d1d06b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"I work with an insurance company so I see lots of requests for stuff. When I see high stimulator volumes I'm suspicious. I deny a lot from some high volume implanters They do 5X more surgeries. You can make money on the trial, but you usually don't make money on the implant. And there have been a lot of patients who are just trialed for no reason by shitty doctors just wanting to making money on the trial knowing full-well they're not going to proceed with the implant. There's a lot of crap going on in that regard. That's been ripe for abuse.\" — KOL; \"We used to do a lot of trials and they were quite lucrative. Especially for a guy like me who did a lot and I'm kind of aggressive, like with my billing. They used to pay us per lead. So if you put in four leads, you'd make a lot of money. I would buy the equipment myself so that's where all the money was instead of the hospital buying the equipment. There were a bunch of guys that were just putting in all these trials on Medicare patients, where you don't have to get authorization. One day a week, they'd line up 10 or 12 of them. Put the trials in and I don't know if they even cared about implanting a device after the trials.\" — High volume KOL",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b34b-59553ca159aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e44dd5c-c486-440d-9c2f-bebb9ddefc98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.88,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c053200-d356-4ece-994c-21689cbf8abf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b232cd96-acb7-4e76-ba52-c7deb87b390a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "cf1b39af-0f7d-4738-b5b9-dc8ad88166ce",
      "evidence": "Uses expert testimony to allege systemic abuse and financial exploitation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}